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One of the significant problems of modern medical and pharmaceuticals chemistry is developing
of selective preparations for the targeted delivery of drugs. This problem is most actually for anti-cancer drugs,
the high toxicity of which leads to substantial side effects. One of the ways of creating selective anti-cancer
drugs is the developing of various types of liposome-encapsulated anti-cancer drugs [1]. The accumulation
of liposome drugs in the tumor tissue is caused by the effect of high permeability of the tumor capillaries [2, 3].
The targeted delivery and the selective accumulation of drugs in tumor can be effectively actualized
with using magnetic liposome preparations of drugs operated by an external magnetic field. Consequently,
developing of magnetic liposomal forms of the known anti-cancer drugs remains a significant interest [4, 5].
The aim of this research is developing of the optimal method to obtain magnetic liposomes carrying





By the method of high temperature decomposition of organic iron salt in a high boiling solvent, homo-
geneous in form and shape magnetite nanoparticles with the average diameter of 7,2 ±1,2 nm were synthesized,
capable of forming stable hydrosols without any additional surface modification.
Magnetic liposomes carrying hydrochloride of daunorubicin were obtained by the method of dehydra-
tion-rehydration of a thin phospholipid film by hydrosol magnetite with subsequent ultrasonication and freeze-
thaw treatment of phospholipid mixtures. The effect of the number of freeze-thaw treatments and the time
of ultrasonication on the size and stability of obtained magnetic liposomes was researched and chosen
the optimal parameters of a process. The average size of obtained magnetic liposomes carrying daunorubicin
equal to 158,2 ±31,9 nm is in the range of 90 to 200 nm, which is optimal for anti-cancer therapy [6].
Synthesized nanoparticles of magnetite and magnetic liposomes loaded with daunorubicin on its basis
were characterized by transmission electron microscopy (TEM), selected area electron diffraction (SAED),
dynamic light scattering (DLS) and Faraday balance magnetometer.
The obtained magnetic liposomes encapsulated with daunorubicin are perceptively for targeted delivery
and accumulation of daunorubicin in tumor.
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